试用视觉搜索
使用图片进行搜索，而不限于文本
你提供的照片可能用于改善必应图片处理服务。
隐私策略
|
使用条款
在此处拖动一张或多张图像或
浏览
在此处放置图像
或
粘贴图像或 URL
拍照
单击示例图片试一试
了解更多
要使用可视化搜索，请在浏览器中启用相机
English
全部
图片
灵感
创建
集合
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
自动播放所有 GIF
在这里更改自动播放及其他图像设置
自动播放所有 GIF
拨动开关以打开
自动播放 GIF
图片尺寸
全部
小
中
大
特大
至少... *
自定义宽度
x
自定义高度
像素
请为宽度和高度输入一个数字
颜色
全部
彩色
黑白
类型
全部
照片
插图
素描
动画 GIF
透明
版式
全部
方形
横版
竖版
人物
全部
脸部特写
半身像
日期
全部
过去 24 小时
过去一周
过去一个月
去年
授权
全部
所有创作共用
公共领域
免费分享和使用
在商业上免费分享和使用
免费修改、分享和使用
在商业上免费修改、分享和使用
详细了解
重置
安全搜索:
中等
严格
中等（默认）
关闭
筛选器
620×415
www.lifesciencesipreview.com
Patients in a test tube: Horizon Discovery's IP strategy | Life Scien…
620×400
www.lifesciencesipreview.com
Trump to ‘streamline’ the FDA and lower drug prices | Life Sciences Int…
1280×720
www.lifesciencesipreview.com
Moderna’s COVID-19 pledge dilemma | Europe | Life Sciences Intellectual Propert…
620×412
www.lifesciencesipreview.com
US Trade Representative Special 301 report hits out at Indian pharm…
620×413
www.lifesciencesipreview.com
Reaching out: BIO abroad | Life Sciences Intellectual Property Review
620×454
www.lifesciencesipreview.com
US Supreme Court agrees to hear Teva’s Copaxone appeal in case …
620×400
www.lifesciencesipreview.com
Peru accepts WTO’s TRIPS amendment on affordable medicines | Life Science…
620×414
www.lifesciencesipreview.com
A new approach to cancer target screening | Life Sciences Intellectual …
640×427
www.lifesciencesipreview.com
New horizons: biotech guidelines in Brazil | Life Sciences Intellectual Pro…
620×414
www.lifesciencesipreview.com
IP Australia suggests changes to plant breeders’ rights committee | Life Scie…
620×414
www.lifesciencesipreview.com
Myriad and Gene by Gene settle BRCA genetic testing litigation | Life Scienc…
620×414
www.lifesciencesipreview.com
New rules on filing patents after the AIA | Life Sciences Intellectual Prope…
611×400
www.lifesciencesipreview.com
Challenges to the patenting of “essentially biological processes” in I | Life Sciences ...
600×424
www.lifesciencesipreview.com
Great expectations | Life Sciences Intellectual Property Review
620×412
www.lifesciencesipreview.com
Canadian government responds to Lilly’s NAFTA complaint | Life Sciences Intelle…
620×502
www.lifesciencesipreview.com
The Bolar exemption at the CJEU: the question of third part…
620×527
www.lifesciencesipreview.com
Myriad: Keeping a low profile | Life Sciences Intellectual Prop…
600×437
www.lifesciencesipreview.com
A bright future for AstraZeneca? | Life Sciences Intellectual Property Review
620×400
www.lifesciencesipreview.com
Jawbone’s patents cover ‘basic and abstract concept’, ITC rules | Life Science…
620×400
www.lifesciencesipreview.com
Case report: Biocon’s breast cancer biosimilar gets green light | Life Sciences …
1280×853
www.lifesciencesipreview.com
LSPN Spring: Preliminary injunctions ‘a focal point’ in UPC decisions | Eur…
620×400
www.lifesciencesipreview.com
TPP abandonment: the fallout for biotech and pharma | Life Sciences Int…
620×414
www.lifesciencesipreview.com
Patent term restoration and adjustment in Mexico: a TPP possibi…
620×400
www.lifesciencesipreview.com
LSIPR 50 2018: Tim Moss —Uniting the IP chorus | Life Sciences Intellectual …
600×416
www.lifesciencesipreview.com
A changing landscape: approving biosimilar products in Mexico | Life …
620×365
www.lifesciencesipreview.com
Second and further medical use claims and the EPC 2000 | Life Sciences Intellectual P…
620×400
www.lifesciencesipreview.com
Federal Circuit rules ‘treatment claims’ are patent eligible | Life Sciences Intell…
640×493
www.lifesciencesipreview.com
Inter partes review: The unintended consequences of IP…
620×400
www.lifesciencesipreview.com
LSPN 2016: UPC Agreement hasn’t reached a safe harbour yet | Life Scie…
620×400
www.lifesciencesipreview.com
UK Parliament votes for UK to stay in European Medicines Agency | Life Sc…
620×400
www.lifesciencesipreview.com
Federal Circuit affirms USPTO’s ruling over Relenza | Life Sciences Intellect…
620×400
www.lifesciencesipreview.com
Par Pharmaceutical sued for patent infringement | Life Sciences Intellectu…
620×400
www.lifesciencesipreview.com
Why CRISPR may define pre- and post-AIA changes | Life Sciences Intellectual Property Review
640×441
www.lifesciencesipreview.com
Sanders: US must back WTO drug patent request for poor countries | Life Sciences Intellectual ...
620×413
www.lifesciencesipreview.com
Genomic Vision's IP strategy | Life Sciences Intellectual Property Review
某些结果已被隐藏，因为你可能无法访问这些结果。
显示无法访问的结果
报告不当内容
请选择下列任一选项。
无关
低俗内容
成人
儿童性侵犯
Invisible focusable element for fixing accessibility issue
反馈
反馈
.jpg%2fr%5bwidth%5d%3d1280%2fa6781c50-0e1b-11ef-a956-87ed2b3f1c3c-IMG_9985+(1).jpg&cdnurl=https%3a%2f%2fth.bing.com%2fth%2fid%2fR.cb96963ec2703fb53321ad05decd38d3%3frik%3dicpweA5RCUMNiw%26pid%3dImgRaw%26r%3d0&exph=853&expw=1280&q=site%3awww.lifesciencesipreview.com&simid=608011801765428396&FORM=IRPRST&ck=3F78BDBAA57A8874EEAD671064F3A3F2&selectedIndex=20&itb=0)
